Farmas USA (10671/17172)

#85361

Re: Farmas USA

17/03/16 11:56

Con AMRN no toco de momento, no me gusta los movimientos que ha hecho y estar "pillado" en NVAX no me quita el sueño, en AMRN me lo quitaría sin duda.

Quizás juegue un poco con NVAX, entradas y salidas con poco beneficio, si no sale bien pues a esperar.

Responder

#85362

Re: Farmas USA

Top 10

framus_morrigan

Seguir

17/03/16 13:16

Novavax Appoints Bob Darius Senior Vice President, Quality Operations

http://ir.novavax.com/phoenix.zhtml?c=71178&p=irol-newsArticle&ID=2149204

25 years of experience in Quality Assurance, Quality Control and strategic manufacturing. As VP Quality Operations at GlaxoSmithKline (GSK) Biologicals, he provided oversight of the North American and German Vaccine Manufacturing Operations for over 10 years and most recently transitioned to Head Quality Advocacy Liaison. Mr. Darius also held positions of increasing responsibility at the Food and Drug Administration, Center for Biologics Evaluation and Research

NVAX

Responder

#85363

Re: Farmas USA

Top 100

anaramos

Seguir

17/03/16 13:51

CLSN

Presentation of Preclinical Data for GEN-1 IL-12 Immunotherapy in Combination with Avastin® and Doxil® at the AACR Annual Meeting 2016

The presentation will be held on Monday, April 18, 2016 (1:00 pm to 5:00 pm) and will summarize results from preclinical studies demonstrating significant synergistic anti-cancer effects when GEN-1 is combined with Avastin® and Doxil®.

These data will be used by the Company to support a comprehensive IND protocol filing for a Phase I/II clinical trial evaluating the combination in recurrent ovarian cancer later this year.

http://investor.celsion.com/releaseDetail.cfm?ReleaseID=961017